|
SECOND ANNUAL SUMMIT ON DISCLOSURE, TRANSPARENCY AND
AGGREGATE SPEND FOR DRUG, DEVICE AND BIOTECH COMPANIES
A Pharma Congress Conference
March 3 - 5, 2010
|
ONSITE
Renaissance Washington DC Hotel
Washington, DC
|
OR |
ONLINE
In your own office or home live via the Internet
with 24/7 access for six months
|
 |
|
|
CO CHAIRS
|
Eve Costopoulos
Vice President, Merck & Co., Inc., Summit, NJ |
Jonathon L. Kellerman
Principal, Pharmaceutical and Life Sciences Advisory Services, PricewaterhouseCoopers LLP, Florham Park, NJ |
Daniel A. Kracov, Esq.
Partner, Arnold & Porter, Washington, DC |
Paul J. Silver
Managing Director, Huron Consulting Group, LLC, Atlanta, GA |
Jack T. Tanselle
Director, Navigant Consulting, Inc., Chicago, IL |
Michael Varlotta
Senior Director, Department of Medical Education, Medical Affairs, Centocor, a wholly owned subsidiary of Johnson & Johnson, Horsham, PA
|
|
|
|
|
FEDERAL AND STATE POLICY MAKERS
|
Christopher J. Armstrong, Esq.
Investigative Counsel, Committee on Finance, US Senate, Staff, Senator Charles Grassley, Ranking Member, Washington, DC |
Jack Mitchell
Chief of Oversight and Investigations, Special Committee on Aging, US Senate, Staff, Senator Herb Kohl (D/WI), Washington, DC |
George Till, MD
State Legislator, Vermont, Underhill, VT
|
|
|
|
|
FEDERAL AND STATE PROSECUTORS AND REGULATORS
|
Julie Brill, Esq.
Senior Deputy Attorney General, Chief, Consumer Protection Division, North Carolina Department of Justice, Raleigh, NC |
Melissa J. Lopes, Esq.
Deputy General Counsel, Massachusetts Department of Public Health, Boston, MA |
Mary E. Riordan, Esq.
Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Washington, DC
|
James G. Sheehan, Esq.
New York State Medicaid, Inspector General, Former Associate United States Attorney, US Attorney's Office, Eastern District of Pennsylvania, Albany, NY |
Gerald Sullivan, Esq.
Assistant United States Attorney, US Attorney's Office, Eastern District of Pennsylvania, Philadelphia, PA
|
|
|
|
|
POLICY EXPERTS
|
Guy M. Chisolm, III, PhD
Director, Innovation Management and Conflict of Interest Program, Vice Chairman, Lerner Research Institute, Cleveland Clinic, Cleveland, OH |
Bernard Lo, MD
Professor of Medicine and Director Program in Medical Ethics, Department of Medicine, University of California, San Francisco, Chair, Committee on Conflict of Interest in Medical Research, Education, and Practice; Institute of Medicine, San Francisco, CA |
Frank W. LoGerfo, MD
William V. McDermott Distinguished Professor of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
|
James Roosevelt, Jr., Esq.
President and Chief Executive Officer, Tufts Health Plan, Former Associate Commissioner for Retirement Policy, US Social Security Administration, Boston, MA |
Thomas P. Stossel, MD
Director, Translational Medicine Division, Senior Physician, Hematology Division, American Cancer Society, Professor of Medicine, Brigham & Womens Hospital, Harvard Medical School, Boston, MA
|
|
|
|
|
COMPLIANCE PROFESSIONALS AND INHOUSE COUNSEL
|
Diane Cruz-Burke, Esq.
Assistant General Counsel, Eli Lilly and Company, Indianapolis, IN |
David Eiben
Associate Director, Promotional Services, Boehringer Ingelheim, Ridgefield, CT |
Jacqueline K. Huber
Corporate Vice President and Chief Compliance Officer, Biomet, Inc., Warsaw, IN
|
Beth Margerison
Associate Director, Ethics and Compliance, Novartis Pharmaceuticals Corporation, East Hanover, NJ |
Rore Middleton
Corporate Compliance Consultant, Purdue Pharma, Stamford, CT |
Brian S. McGowan, PhD, CCMEP
Senior Director, Independent Medical Education, Pfizer, Collegeville, PA
|
Una Nash
Associate Director Marketing and Sales Compliance, Boehringer Ingelheim, Ridgefield, CT |
Jeffrey S. Paden
Compliance Director, GlaxoSmithKline, Research Triangle Park, NC |
Heather Reilly Powell, Esq.
Director, Compliance Training and Reporting, Daiichi Sankyo, Inc., Former Associate Director, Global Compliance, Cephalon, Inc., Parsippany, NJ
|
Geralyn Ritter
Vice President, Global Public Policy and Corporate Responsibility, Merck & Co., Inc., Former Senior VP, International Affairs, PhRMA, White Plains, NY |
Trudy J. Seeley, Esq.
Compliance Manager, State Law Compliance, and US Corporate Compliance, sanofi-aventis, Bridgewater, NJ |
Betsy Van Hecke
Vice President Ethics and Compliance, MedTronic Spinal and Biologics, Minneapolis, MN
|
|
|
|
|
A PANEL OF COMPLIANCE TECHNOLOGY EXPERTS
|
Michael Bell, Esq.
President, R-Squared, Princeton Junction, NJ |
Mitch Chi
Senior Vice President Sales, Health Market Science, King of Prussia, PA |
Kim Life, Esq.
Principal, Life Compliance Solutions, Former Associate Director, Business Conduct, Gilead Sciences, San Francisco, CA (Moderator)
|
John Patrick Oroho, Esq.
Executive Vice President, Porzio Pharmaceutical Services, Principal, Porzio, Bromberg & Newman PC, Morristown, NJ |
Don Soong
Senior Director, Compliance Solutions Development, Cegedim Dendrite, Bedminster, NJ
|
|
|
|
|
ADVISORS AND LEGAL COUNSEL
|
Eric M. Baim, Esq.
Associate, Hogan & Hartson, Washington, DC |
John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP, Former Special Counsel for Healthcare Fraud and Chief Privacy Officer, US Department of Justice, Washington, DC |
Jennifer Colapietro
Director, Pharmaceutical and Life Sciences Advisory Services, PricewaterhouseCoopers, Florham Park, NJ
|
Daniel F. Donovan, III, Esq.
Partner, Government Advocacy & Public Policy Practice Group , King & Spalding, Former Senior Investigative Counsel to Senator Charles E. Grassley (R-IA), Committee on Finance, US Senate, Washington, DC |
Michael N. Druckman, Esq.
Partner, Hogan & Hartson, Washington, DC |
Sarah K. Giesting, Esq.
Associate, Epstein Becker & Green, New York, NY
|
Jeffrey L. Handwerker, Esq.
Partner, Arnold & Porter, Washington, DC |
Marci Juneau
Manager, Life Sciences Advisory Services, Huron Consulting Group, Atlanta, GA |
William A. Sarraille, Esq.
Partner, Sidley Austin Brown & Wood, Washington, DC
|
William M. Mandell, Esq.
Partner, Pierce & Mandell, PC, Boston, MA |
Thomas Sullivan
President and Founder, Rockpointe Corporation, Columbia, MD
|
Manny Tzavlakis
Director, Life Sciences Advisory Services, Huron Consulting Group, New York, NY |
Jon Wilkenfeld, MBA
President, Potomac River Partners, Vienna, VA |
|
|
|
THE DISCLOSURE SUMMIT CONTENT IS NOW AVAILABLE IN VARIOUS POST CONFERENCE FORMATS
|
You may now purchase the packaged Disclosure Summit Training Program, which includes preconference readings and online courses, the conference video with synchronized PowerPoint presentations and the post conference online exam. This content is perfect for corporate compliance training programs and can be purchased at deep group discounts. Click here for more info.
Alternatively, you may purchase just the Summit streaming content in the following formats: Data DVD, iPod™ nano, Flash Drive or online archive (6 months). You may also purchase individual presentations in an online archive (6 months) format. Click here for more info.
|
|
THE TIME IS NOW FOR NEW, EFFICIENT AND COST EFFECTIVE ALTERNATIVES TO TRADITIONAL LEARNING APPROACHES
|
|
A variety of forces - the nation's economic crisis, costly and difficult air travel, the mandate for cost efficiency in healthcare, the proliferation of greater Internet bandwidth, the emergence of the popularity of online video via You Tube, and the explosion of online training in the health sector - has come together to create both a dramatic need and an extraordinary opportunity for innovative approaches to sharing new ideas and best practices. This Summit offers not only traditional conference attendance, but also to opportunity to attend the event live and archived online.
How can we be expected to reform the nation's health system if we can not reform the way we do our own business?
|
|
|
|
PARTICIPATION OPTIONS
|
TRADITIONAL ONSITE ATTENDANCE
Simply register, travel to the conference city and attend in person.
Pros: subject matter immersion; professional networking opportunities; facility interaction
LIVE AND ARCHIVED INTERNET ATTENDANCE
Watch the conference in live streaming video over the Internet and at your convenience
at any time 24/7 for the six months following the event.
The archived conference includes speaker videos and coordinated PowerPoint presentations.
Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away from the office |
|
INTERNET INTERFACE SAMPLE
|
Click here for a sample stream
|
|
|
|
|
THE GROUP REGISTRATION/ONLINE TRAINING ALTERNATIVE
|
|
By arranging to license online group access to the Summit Disclosure Summit Training Program, pharmaceutical, device and biotech companies subject to disclosure and aggregate spend requirements can implement company-wide online training programs. The company training coordinator can assign and track online participation. Successful completion of the training can be evidenced by passing the post conference training examination.
|
|
HERE IS AN EXAMPLE OF A PHARMA COMPANY DISCLOSURE TRAINING PROGRAM
|
|
|
|
|
SAVE THE DATE
|
FOURTH INTERNATIONAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
Sponsored by Pharmaceutical Compliance Forum
May 17 - 19, 2010
Berlin, Germany
www.InternationalPharmaCongress.com
|
|
FIFTH FDA REGULATORY SYMPOSIUM
A Hybrid Conference and Internet Event
Addressing FDA's Regulatory Agenda for 2010 and Beyond
Media Partners: Harvard Health Policy Review and RxCompliance Report
October 2010
Washington, DC
www.FDASymposium.com
|
|
ELEVENTH PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
Transformational Learning - Effective Knowledge Exchange
Sponsored by Pharmaceutical Compliance Forum
Media Partners: Harvard Health Policy ReviewM
November 2010
Washington, DC
www.PharmaCongress.com
|
|
|
|
|
|
